Skip to Content

Buying Comparator Drugs Vs. Comparator Services

Guillaume Brulebois

By: Guillaume Brulebois August 31 2017

Tags: Comparator, Clinical Ancillary Supplies

Comparator Drug vs Comparator Service

Top 4 differences between buying comparator drugs versus buying comparator service

All too often we have new customers asking just for the price to source a specific commercial drug and quantity.  Often they don’t realize that what they really want is a comparator sourcing service.  Numerous factors will impact trial cost besides just the price of the comparator drug. A comprehensive and robust supply chain for your comparator drug across the lifetime of your trial is an important consideration, as a well-defined thought out strategy can ultimately save you significantly in comparator drug costs. It is critical to have a broader, flexible view of comparator sourcing that accommodates trial changes as well as compliance challenges and risks. Although your in-house teams may be knowledgeable on general standards, valuable insight into optimal sourcing solutions can be provided by industry experts closely linked to the comparator market.

Here are some of the top advantages for buying comparator services and the value to your clinical trial:

1.      Market know-how
Based on daily experience with commercial drug sourcing for clinical trials, a strong partner can advise you on the market behavior of a specific product along with the latest trends and reliable sources. This advice is based on score cards and KPI’s for supplier selection, country scorecard on counterfeit risk, QA audits, regular contacts with manufacturers and market price analyses.

2.      Analyzing your trial needs
Based on long-standing experience, this partner will analyze the scope of your sourcing needs. This includes the way you will integrate the commercial drug in your clinical trial (e.g. IMP vs. non-IMP, repackaging, relabeling, countries involved, supply plan, etc.) and its deep impact on the right sourcing solution (e.g. central vs local sourcing, open market vs. direct sourcing, lead-time for resupply, max quantity available, remaining shelf-life, documentation for import/export, etc.).

3.      Matching need against market
Your supplier of choice should then use wide-market know-how to gauge the best strategy, including risk analysis and back-up solutions that enable you to determine quickly if protocol/trial adjustments are needed and if your planned demand matches the global market availability. Moreover, suggestions such as importing comparator drug from EU to US could be made.

4.      Post-sales service
Due to the increase of cold chain drugs, temperature excursion can become one of the costliest components of drug loss and trial delays. Your partner should have strong relationships with numerous manufacturers that enable you to mitigate critical situations rapidly that arise during packaging, shipping and site storage. This requires evaluating time out of the environment against product stability. This is just one example of a post-sales service that should be investigated before buying a comparator drug.

Our goal is to help you formulate the cost-benefit breakdown and make the most efficient decisions for your specific trial. As a result, you will minimize financial and legal risks by engaging our experts, who take a 360-degree view of the clinical supply chain process.

Click below for case study examples of our expertise in action on commercial drug sourcing. Additionally, these related comparator sourcing blogs also might be of interest, click here.

 

Case Study Examples
Guillaume Brulebois